Danish biotech company nominated as most innovative SME in the EU
10 9月 2014
The European Association for Bioindustries (EuropaBio) has announced the top five biotech SMEs in Europe, who will compete to win the award as the ‘Most Innovative EU Biotech SME’. The innovative Danish biotech company, Biosyntia, is among the five contenders.
The Danish company Biosyntia has been chosen as a contender for the ‘Most Innovative EU Biotech SME’ award because of its unique fermentation solutions provided to chemical manufacturing companies. It is especially Biosyntia’s core technology RIBOSELECT that has caught EuropaBio’s attention, as the technology accelerates the discovery of novel enzymes and pathways required for cell factory development and cell factory optimization based on E.coli and yeast.
The top five candidates for this year’s award were selected from a total of 35 applicants. Biosyntia will compete against the UK-based healthcare biotech company, Autifony; the Italian industrial biotech company, Bio-on; the French biopharmaceutical company, Erytech Pharma; and the Dutch biotechnology company, to-BBB.
This year’s annual EuropaBio award ceremony will take place during the European Biotech Week on 8 October 2014 in Brussels.